189 related articles for article (PubMed ID: 22217111)
21. Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial.
Yang WH; Dionne M; Kyle M; Aggarwal N; Li P; Madariaga M; Godeaux O; Vaughn DW
Vaccine; 2013 Sep; 31(40):4389-97. PubMed ID: 23856331
[TBL] [Abstract][Full Text] [Related]
22. A case report of a patient in whom antibodies against the 2009 pandemic influenza A/H1N1 virus have been present since June 1999.
Yoshida M; Sugino H; Iizuka T; Xiaofang L; Suzuki A; Oshitani H; Suzutani T; Ikuta K
Hum Vaccin Immunother; 2013 May; 9(5):989-92. PubMed ID: 23324591
[TBL] [Abstract][Full Text] [Related]
23. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC
PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960
[TBL] [Abstract][Full Text] [Related]
24. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
25. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Issa NC; Marty FM; Gagne LS; Koo S; Verrill KA; Alyea EP; Cutler CS; Koreth J; Armand P; Ho VT; Antin JH; Soiffer RJ; Baden LR
Biol Blood Marrow Transplant; 2011 Mar; 17(3):434-8. PubMed ID: 20950701
[TBL] [Abstract][Full Text] [Related]
26. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
27. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
Yen TY; Jou ST; Yang YL; Chang HH; Lu MY; Lin DT; Lin KH; Huang LM; Chang LY
Pediatr Blood Cancer; 2011 Dec; 57(7):1154-8. PubMed ID: 21425448
[TBL] [Abstract][Full Text] [Related]
28. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
[TBL] [Abstract][Full Text] [Related]
29. "Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?".
Allwinn R; Bickel M; Lassmann C; Wicker S; Friedrichs I
Med Microbiol Immunol; 2013 Apr; 202(2):125-30. PubMed ID: 22986732
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.
Talbot HK; Coleman LA; Zhu Y; Spencer S; Thompson M; Cheng PY; Sundaram ME; Belongia EA; Griffin MR
BMC Infect Dis; 2015 Apr; 15():195. PubMed ID: 25903659
[TBL] [Abstract][Full Text] [Related]
31. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.
Sarsenbayeva G; Volgin Y; Kassenov M; Issagulov T; Bogdanov N; Sansyzbay A; Stukova M; Buzitskaya Z; Кulmagambetov I; Davlyatshin T; Khairullin B
Hum Vaccin Immunother; 2018 Mar; 14(3):609-614. PubMed ID: 29112488
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children.
de Armas LR; George V; Filali-Mouhim A; Steel C; Parmigiani A; Cunningham CK; Weinberg A; Trautmann L; Sekaly RP; Cameron MJ; Pahwa S
Front Immunol; 2021; 12():639358. PubMed ID: 33868267
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.
Zhou Y; Ng DM; Seto WH; Ip DK; Kwok HK; Ma ES; Ng S; Lau LL; Peiris JS; Cowling BJ
PLoS One; 2011; 6(11):e27169. PubMed ID: 22102878
[TBL] [Abstract][Full Text] [Related]
35. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
36. Declining responsiveness to influenza vaccination with progression of human pregnancy.
Schlaudecker EP; Ambroggio L; McNeal MM; Finkelman FD; Way SS
Vaccine; 2018 Jul; 36(31):4734-4741. PubMed ID: 29941326
[TBL] [Abstract][Full Text] [Related]
37. Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus.
Air GM; Feng J; Chen T; Joachims ML; James JA; Thompson LF
J Clin Immunol; 2011 Oct; 31(5):900-12. PubMed ID: 21732013
[TBL] [Abstract][Full Text] [Related]
38. Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.
Ross TM; Lin CJ; Nowalk MP; Huang HH; Spencer SM; Shay DK; Sambhara S; Sundaram ME; Friedrich T; Sauereisen S; Bloom CE; Zimmerman RK
Hum Vaccin Immunother; 2014; 10(5):1195-203. PubMed ID: 24614078
[TBL] [Abstract][Full Text] [Related]
39. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
40. Antibody Responses to Trivalent Inactivated Influenza Vaccine in Health Care Personnel Previously Vaccinated and Vaccinated for The First Time.
Huang KA; Chang SC; Huang YC; Chiu CH; Lin TY
Sci Rep; 2017 Jan; 7():40027. PubMed ID: 28098157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
